MeSH term
Frequency | Condition_Probility | *Cleavage Stage, Ovum | 2 | 1.0 |
Embryo Transfer/*standards | 2 | 1.0 |
Female | 194 | 0.0 |
Humans | 720 | 0.0 |
Meta-Analysis | 2 | 1.0 |
Pregnancy | 18 | 0.0 |
Pregnancy Outcome | 2 | 0.0 |
Pregnancy Rate | 2 | 1.0 |
Pregnancy, Multiple | 2 | 1.0 |
Randomized Controlled Trials | 4 | 0.0 |
Review Literature | 2 | 1.0 |
Acute Disease | 3 | 0.0 |
Adult | 119 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 92 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Animals | 460 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Gene Expression | 36 | 0.0 |
Child | 30 | 0.0 |
Gene Library | 6 | 0.0 |
*Genome, Human | 2 | 0.0 |
Male | 213 | 0.0 |
Molecular Sequence Data | 72 | 0.0 |
Nucleic Acid Hybridization | 6 | 0.0 |
Polymerase Chain Reaction | 26 | 0.0 |
*Polymorphism, Genetic | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 448 | 0.0 |
Sequence Deletion | 5 | 0.0 |
*Adaptor Proteins, Signal Transducing | 5 | 0.0 |
Axotomy | 8 | 30.0 |
Blotting, Western | 26 | 0.0 |
Brain-Derived Neurotrophic Factor/metabolism/*pharmacology | 4 | 100.0 |
Gene Expression Regulation | 9 | 0.0 |
Immunohistochemistry | 61 | 0.0 |
In Situ Hybridization | 30 | 1.0 |
Plasmids | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
RNA, Messenger/analysis | 20 | 0.0 |
Rats | 238 | 1.0 |
Rats, Sprague-Dawley | 83 | 3.0 |
Rats, Wistar | 31 | 2.0 |
Receptors, Nerve Growth Factor/metabolism | 15 | 41.0 |
Reverse Transcriptase Polymerase Chain Reaction | 34 | 0.0 |
Signal Transduction | 27 | 0.0 |
Neurons/drug effects/*physiology | 4 | 13.0 |
Stem Cells/*physiology | 2 | 3.0 |
Animals, Newborn | 15 | 2.0 |
Blotting, Northern | 16 | 0.0 |
Brain-Derived Neurotrophic Factor/biosynthesis/genetics | 5 | 83.0 |
Gene Expression/drug effects | 5 | 0.0 |
Mice | 147 | 0.0 |
Mice, Inbred ICR | 3 | 1.0 |
RNA, Messenger/*biosynthesis | 11 | 4.0 |
Cell Differentiation/drug effects | 16 | 1.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 10 | 7.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Lithium/pharmacology | 3 | 15.0 |
Mitogen-Activated Protein Kinase 3 | 5 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Neurons/cytology/drug effects/*metabolism | 7 | 18.0 |
Phosphorylation/drug effects | 11 | 1.0 |
*Protein-Serine-Threonine Kinases | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 231 | 0.0 |
Signal Transduction/*drug effects/physiology | 2 | 3.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Transfection | 46 | 0.0 |
Tretinoin/pharmacology | 13 | 4.0 |
Tumor Cells, Cultured | 35 | 0.0 |
Acetylcholine/metabolism | 2 | 6.0 |
Brain/*physiology | 7 | 5.0 |
Brain-Derived Neurotrophic Factor/analysis/*genetics | 2 | 100.0 |
Cognition/physiology | 2 | 6.0 |
Learning/physiology | 4 | 26.0 |
Neuronal Plasticity/*physiology | 13 | 27.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
gamma-Aminobutyric Acid/metabolism | 4 | 12.0 |
Brain/*metabolism | 12 | 2.0 |
*Evolution | 3 | 1.0 |
Longevity/*physiology | 2 | 40.0 |
*Signal Transduction | 7 | 0.0 |
Aging/*physiology | 2 | 0.0 |
Aged | 74 | 0.0 |
Cognition Disorders/*drug therapy | 2 | 66.0 |
Cytokines/physiology | 5 | 2.0 |
English Abstract | 36 | 0.0 |
Nociceptors/*physiology | 3 | 23.0 |
Pain/*physiopathology | 3 | 10.0 |
Calcimycin/pharmacology | 2 | 0.0 |
Receptor, trkB/metabolism | 14 | 87.0 |
Stress, Mechanical | 3 | 1.0 |
Brain/metabolism | 9 | 1.0 |
Neurons, Afferent/metabolism | 3 | 25.0 |
Case-Control Studies | 22 | 0.0 |
Child, Preschool | 18 | 0.0 |
Infant | 24 | 0.0 |
Prospective Studies | 4 | 0.0 |
Adolescent | 29 | 0.0 |
Age of Onset | 11 | 0.0 |
Alleles | 16 | 0.0 |
Amino Acid Substitution | 4 | 0.0 |
Brain-Derived Neurotrophic Factor/*genetics | 48 | 100.0 |
Chromatography, High Pressure Liquid/methods | 2 | 1.0 |
DNA Mutational Analysis | 3 | 0.0 |
Gene Frequency | 15 | 0.0 |
Genotype | 27 | 0.0 |
Haplotypes | 3 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Polymorphism, Single Nucleotide | 4 | 0.0 |
Blotting, Western/methods | 5 | 2.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Cell Count/methods | 4 | 7.0 |
Cells, Cultured | 105 | 0.0 |
Dose-Response Relationship, Drug | 32 | 0.0 |
Embryo | 14 | 4.0 |
Enzyme Inhibitors/pharmacology | 20 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 11 | 5.0 |
Glutamate Decarboxylase/metabolism | 2 | 11.0 |
Immunohistochemistry/methods | 10 | 1.0 |
Neurons/*drug effects/physiology | 2 | 20.0 |
Prosencephalon/*cytology | 2 | 66.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 2 | 0.0 |
RNA, Messenger/biosynthesis | 27 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 10 | 3.0 |
Time Factors | 44 | 0.0 |
Tubulin/metabolism | 5 | 5.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 7 | 1.0 |
3T3 Cells | 15 | 0.0 |
Brain-Derived Neurotrophic Factor/pharmacology | 37 | 78.0 |
Cell Survival/drug effects | 31 | 2.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Nerve Growth Factor/*metabolism/pharmacology | 3 | 42.0 |
Nerve Growth Factors/pharmacology | 19 | 23.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Neurons/cytology/drug effects/metabolism | 4 | 21.0 |
Neurotrophin 3/pharmacology | 4 | 57.0 |
PC12 Cells | 15 | 4.0 |
Proto-Oncogene Proteins/genetics/metabolism | 3 | 1.0 |
Signal Transduction/drug effects/*physiology | 5 | 2.0 |
Brain-Derived Neurotrophic Factor/*metabolism | 34 | 100.0 |
Coronary Arteriosclerosis/*metabolism | 2 | 33.0 |
Mast Cells/*metabolism | 2 | 5.0 |
Metabolic Syndrome X/*metabolism | 2 | 40.0 |
Middle Aged | 97 | 0.0 |
Nerve Growth Factor/*metabolism | 4 | 66.0 |
Blood Platelets/metabolism | 2 | 1.0 |
Brain/physiopathology | 2 | 3.0 |
Brain-Derived Neurotrophic Factor/*blood | 10 | 100.0 |
Enzyme-Linked Immunosorbent Assay | 27 | 0.0 |
Psychiatric Status Rating Scales | 3 | 1.0 |
Reference Values | 15 | 0.0 |
Sex Factors | 6 | 0.0 |
Brain-Derived Neurotrophic Factor/metabolism | 23 | 85.0 |
Cell Death | 4 | 1.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Cell Survival | 23 | 2.0 |
Electroencephalography | 3 | 1.0 |
Hippocampus/metabolism | 9 | 9.0 |
Models, Genetic | 2 | 0.0 |
Mutation | 15 | 0.0 |
Neurons/*metabolism | 13 | 4.0 |
Immunoenzyme Techniques | 14 | 0.0 |
Nerve Growth Factors/*metabolism | 26 | 32.0 |
Neurotrophin 3/metabolism | 5 | 100.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 12 | 4.0 |
Signal Transduction/*physiology | 11 | 0.0 |
Adaptation, Physiological | 2 | 2.0 |
Aging/*metabolism | 6 | 2.0 |
*Neuronal Plasticity | 6 | 31.0 |
Serotonin/*metabolism | 5 | 10.0 |
Cell Survival/drug effects/physiology | 10 | 12.0 |
Electrophysiology | 2 | 0.0 |
Guinea Pigs | 3 | 0.0 |
Infusion Pumps, Implantable | 3 | 17.0 |
Amino Acid Sequence | 43 | 0.0 |
Binding Sites | 11 | 0.0 |
Circular Dichroism | 8 | 1.0 |
Kinetics | 20 | 0.0 |
Models, Molecular | 11 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Sequence Homology, Amino Acid | 13 | 0.0 |
Motor Activity | 2 | 4.0 |
Base Sequence | 43 | 0.0 |
*Genetic Vectors | 4 | 1.0 |
Mice, Transgenic | 21 | 0.0 |
CHO Cells | 8 | 0.0 |
Culture Media, Conditioned | 4 | 1.0 |
Escherichia coli/genetics | 3 | 0.0 |
Hamsters | 9 | 0.0 |
Protein Conformation | 13 | 0.0 |
Protein Structure, Secondary | 6 | 0.0 |
Temperature | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Syndrome | 2 | 0.0 |
*Variation (Genetics) | 5 | 0.0 |
Brain-Derived Neurotrophic Factor/*metabolism/pharmacology | 5 | 100.0 |
Culture Techniques | 5 | 1.0 |
Mice, Inbred C57BL | 13 | 0.0 |
DNA Primers | 12 | 0.0 |
*Gene Expression | 3 | 0.0 |
Nerve Growth Factors/*genetics/metabolism | 3 | 33.0 |
Neuroglia/cytology/*metabolism | 2 | 11.0 |
RNA, Messenger/metabolism | 26 | 0.0 |
Receptors, Nerve Growth Factor/*genetics/metabolism | 3 | 60.0 |
Brain Chemistry | 9 | 3.0 |
Brain-Derived Neurotrophic Factor/*analysis | 7 | 100.0 |
Neurons/*chemistry | 2 | 6.0 |
Neuroprotective Agents/analysis | 2 | 66.0 |
Receptor, trkB/*analysis | 2 | 100.0 |
Brain/cytology/metabolism | 2 | 5.0 |
Brain-Derived Neurotrophic Factor/genetics/*metabolism | 9 | 90.0 |
Calcium/metabolism | 8 | 0.0 |
Exons/genetics | 3 | 0.0 |
Gene Expression Regulation/*physiology | 4 | 1.0 |
Genes, Reporter | 3 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Rats, Long-Evans | 3 | 6.0 |
Tissue Distribution | 7 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Cell Line, Transformed | 7 | 0.0 |
Cell Separation | 3 | 0.0 |
Cell Transplantation | 3 | 3.0 |
DNA Primers/chemistry | 4 | 0.0 |
Fluorescent Antibody Technique, Indirect | 4 | 0.0 |
Lymphocyte Activation | 4 | 0.0 |
Neurons/drug effects | 5 | 21.0 |
Species Specificity | 7 | 0.0 |
Cell Count | 18 | 1.0 |
*Environment | 3 | 6.0 |
Neuronal Plasticity/physiology | 8 | 19.0 |
Double-Blind Method | 3 | 0.0 |
Placebos | 2 | 0.0 |
Aged, 80 and over | 33 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Homozygote | 6 | 0.0 |
Parkinson Disease/*genetics | 4 | 4.0 |
Polymorphism, Single Nucleotide/*genetics | 4 | 1.0 |
Ubiquitin Thiolesterase | 4 | 3.0 |
Ligands | 7 | 0.0 |
Models, Biological | 9 | 0.0 |
Nerve Growth Factors/metabolism | 15 | 25.0 |
Protein Binding | 10 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 2 | 0.0 |
Brain-Derived Neurotrophic Factor/genetics | 13 | 86.0 |
*Drosophila Proteins | 4 | 0.0 |
Fetus | 13 | 2.0 |
*Membrane Glycoproteins | 5 | 0.0 |
Nerve Growth Factors/*genetics | 13 | 23.0 |
Nerve Tissue Proteins/*genetics | 16 | 2.0 |
Neurotrophin 3/genetics | 2 | 66.0 |
Proto-Oncogene Proteins/genetics | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics | 5 | 3.0 |
Receptor, trkB/genetics | 3 | 75.0 |
*Receptors, Nerve Growth Factor | 2 | 22.0 |
Cell Differentiation/*physiology | 5 | 2.0 |
Infant, Newborn | 16 | 0.0 |
Serotonin/metabolism | 7 | 8.0 |
Respiratory Function Tests | 2 | 1.0 |
B-Lymphocytes/*metabolism | 3 | 1.0 |
Membrane Glycoproteins/metabolism | 3 | 0.0 |
Mice, Inbred Strains | 5 | 0.0 |
Nerve Growth Factor/metabolism | 7 | 28.0 |
Nerve Growth Factors/genetics/*metabolism | 7 | 31.0 |
Peptide Fragments/metabolism | 4 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 5 | 0.0 |
Brain-Derived Neurotrophic Factor/analysis/metabolism | 2 | 100.0 |
Clinical Trials | 6 | 0.0 |
Glutamic Acid/metabolism | 2 | 4.0 |
Cell Death/drug effects | 8 | 5.0 |
Cell Line | 39 | 0.0 |
Furin | 3 | 6.0 |
Neurons/cytology/drug effects | 3 | 27.0 |
Protein Processing, Post-Translational | 5 | 0.0 |
Receptor, trkA/metabolism | 6 | 42.0 |
Subtilisins/metabolism | 2 | 13.0 |
Antidepressive Agents/therapeutic use | 3 | 15.0 |
Chronic Disease | 5 | 0.0 |
Cyclic AMP/metabolism | 6 | 1.0 |
Signal Transduction/drug effects | 4 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Brain-Derived Neurotrophic Factor/*biosynthesis/genetics | 9 | 100.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Receptor, trkB | 6 | 85.0 |
Receptor, trkC | 21 | 67.0 |
Memory/*physiology | 8 | 12.0 |
*Polymorphism, Single Nucleotide | 5 | 0.0 |
Aggression | 2 | 16.0 |
Disease Models, Animal | 29 | 1.0 |
Nerve Growth Factors/*pharmacology | 47 | 37.0 |
Brain/*pathology | 4 | 2.0 |
Neurotrophin 3/*analysis | 2 | 100.0 |
Epidermal Growth Factor/*pharmacology | 2 | 0.0 |
Fibroblast Growth Factor 2/pharmacology | 6 | 2.0 |
Brain-Derived Neurotrophic Factor/genetics/therapeutic use | 2 | 100.0 |
*Cell Transplantation | 2 | 7.0 |
Laterality | 3 | 5.0 |
Calcium/*physiology | 2 | 1.0 |
*Gene Expression Regulation | 8 | 0.0 |
Models, Neurological | 10 | 7.0 |
Neurons/*physiology | 10 | 6.0 |
Synapses/physiology | 4 | 10.0 |
Synaptic Transmission | 4 | 10.0 |
Receptors, Nerve Growth Factor/*metabolism | 15 | 32.0 |
Bipolar Disorder/epidemiology/*genetics | 2 | 33.0 |
Gene Frequency/genetics | 7 | 1.0 |
Linkage Disequilibrium/*genetics | 2 | 2.0 |
Longitudinal Studies | 2 | 0.0 |
Apolipoproteins E/*genetics | 2 | 0.0 |
Chi-Square Distribution | 5 | 0.0 |
Cognition/*physiology | 3 | 4.0 |
Polymerase Chain Reaction/methods | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Analysis of Variance | 15 | 0.0 |
Methionine/*genetics | 2 | 13.0 |
Polymorphism, Genetic/*genetics | 12 | 0.0 |
Valine/*genetics | 2 | 9.0 |
Culture Media, Serum-Free/pharmacology | 3 | 2.0 |
Facial Nerve/physiology | 2 | 66.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Neck | 2 | 3.0 |
RNA, Messenger/analysis/biosynthesis | 3 | 1.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
In Vitro | 20 | 0.0 |
Pilot Projects | 4 | 0.0 |
Prognosis | 2 | 0.0 |
Receptor, trkB/*metabolism | 11 | 100.0 |
Receptor, trkC/metabolism | 4 | 80.0 |
Risk | 3 | 0.0 |
Survival Analysis | 2 | 0.0 |
Antidepressive Agents/*therapeutic use | 3 | 20.0 |
Hippocampus/*metabolism | 5 | 7.0 |
Schizophrenia/metabolism | 2 | 25.0 |
Bromodeoxyuridine | 3 | 9.0 |
Cell Movement/drug effects | 3 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Injections, Intraventricular | 10 | 7.0 |
Stem Cells/cytology/*drug effects/metabolism | 3 | 33.0 |
Islets of Langerhans/metabolism | 2 | 5.0 |
Up-Regulation | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/*pharmacology | 44 | 100.0 |
Synaptic Transmission/*drug effects/physiology | 2 | 25.0 |
Inflammation | 2 | 0.0 |
Brain-Derived Neurotrophic Factor/analysis | 6 | 100.0 |
Neurotrophin 3/analysis | 3 | 100.0 |
Sensitivity and Specificity | 7 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Cytokines/*pharmacology | 2 | 0.0 |
Interleukin-1/pharmacology | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Combined Modality Therapy | 2 | 0.0 |
Recombinant Proteins/therapeutic use | 2 | 0.0 |
Injections, Spinal | 3 | 8.0 |
Amyotrophic Lateral Sclerosis/*drug therapy | 2 | 33.0 |
Brain-Derived Neurotrophic Factor/*administration & dosage | 4 | 100.0 |
Apoptosis/drug effects | 7 | 1.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Nerve Growth Factors/*physiology | 22 | 50.0 |
Cell Death/drug effects/physiology | 3 | 7.0 |
Cell Differentiation/drug effects/physiology | 6 | 6.0 |
*Nerve Growth Factors | 9 | 4.0 |
Nerve Tissue Proteins/pharmacology | 14 | 33.0 |
Electrophoresis, Polyacrylamide Gel | 6 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Membrane Proteins/genetics/*metabolism | 3 | 1.0 |
*Neural Cell Adhesion Molecule L1 | 2 | 7.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
Phosphorylation | 37 | 0.0 |
Phosphotyrosine/metabolism | 3 | 0.0 |
Mesencephalon/metabolism | 2 | 15.0 |
Nerve Tissue Proteins/*metabolism | 7 | 2.0 |
Parkinson Disease/*metabolism/pathology | 2 | 18.0 |
Genetic Screening | 3 | 0.0 |
Apoptosis | 6 | 0.0 |
Cerebral Cortex/cytology/*metabolism | 3 | 27.0 |
Exons | 4 | 0.0 |
Hippocampus/cytology/metabolism/pathology | 2 | 100.0 |
Nerve Degeneration | 6 | 9.0 |
Nerve Tissue Proteins/genetics/*physiology | 2 | 6.0 |
Neurons/*metabolism/pathology | 3 | 5.0 |
Nuclear Proteins/genetics/*physiology | 2 | 4.0 |
Promoter Regions (Genetics) | 11 | 0.0 |
Transcription, Genetic | 11 | 0.0 |
Receptors, Tumor Necrosis Factor/physiology | 2 | 2.0 |
Structure-Activity Relationship | 7 | 0.0 |
Brain-Derived Neurotrophic Factor/biosynthesis | 9 | 100.0 |
Cell Differentiation/physiology | 8 | 1.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 2 | 0.0 |
Dopamine/metabolism | 8 | 6.0 |
Neuronal Plasticity/drug effects/*physiology | 3 | 42.0 |
Brain-Derived Neurotrophic Factor/administration & dosage/*pharmacology | 5 | 100.0 |
Glucose/metabolism | 3 | 1.0 |
Mice, Mutant Strains | 8 | 1.0 |
Recombinant Proteins/administration & dosage/pharmacology | 5 | 8.0 |
Signal Transduction/drug effects/physiology | 4 | 1.0 |
Injections | 5 | 4.0 |
Vitreous Body | 3 | 21.0 |
Cell Division/drug effects | 16 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Nerve Growth Factor/*pharmacology | 5 | 27.0 |
Receptor, Nerve Growth Factor/metabolism | 3 | 37.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
Autistic Disorder/*blood | 2 | 66.0 |
Mental Retardation/*blood | 2 | 100.0 |
Nerve Growth Factors/*blood | 3 | 8.0 |
Brain-Derived Neurotrophic Factor/*analysis/genetics | 2 | 100.0 |
Neurons/metabolism | 14 | 4.0 |
Treatment Outcome | 7 | 0.0 |
Genetic Markers | 5 | 0.0 |
Receptors, Dopamine D2/genetics | 2 | 4.0 |
Schizophrenia/*genetics | 2 | 0.0 |
Antibodies/pharmacology | 3 | 0.0 |
Antineoplastic Agents/pharmacology | 3 | 0.0 |
Neuroblastoma/*metabolism/pathology | 2 | 5.0 |
Tumor Cells, Cultured/drug effects | 3 | 0.0 |
Dactinomycin/pharmacology | 2 | 0.0 |
Nerve Tissue Proteins/*pharmacology | 26 | 28.0 |
Neuroprotective Agents/*pharmacology | 9 | 13.0 |
Phenotype | 12 | 0.0 |
Protein Biosynthesis/drug effects | 2 | 3.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/biosynthesis/*genetics | 3 | 100.0 |
Cloning, Molecular | 12 | 0.0 |
*Plasmids | 2 | 4.0 |
Disease Progression | 6 | 0.0 |
Lymphatic Metastasis | 2 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Prevalence | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cerebral Cortex/metabolism | 2 | 3.0 |
Crystallography, X-Ray | 4 | 0.0 |
Mice, Knockout | 19 | 0.0 |
Mutation/genetics | 3 | 0.0 |
Protein Transport/physiology | 2 | 1.0 |
Synaptic Transmission/*physiology | 5 | 14.0 |
Aging | 4 | 1.0 |
GAP-43 Protein/*metabolism | 2 | 66.0 |
Neuropeptide Y/*metabolism | 2 | 2.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Neurons/*cytology/metabolism | 2 | 7.0 |
Signal Transduction/physiology | 11 | 1.0 |
Adenocarcinoma/*chemistry/pathology | 2 | 4.0 |
Cell Division | 5 | 0.0 |
Neoplasm Invasiveness | 5 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
*Pancreatic Ducts | 2 | 25.0 |
Pancreatic Neoplasms/*chemistry/pathology | 2 | 22.0 |
Receptors, Nerve Growth Factor/analysis | 5 | 35.0 |
Bone Marrow Cells/cytology | 2 | 2.0 |
Cell Culture Techniques | 6 | 1.0 |
Cytokines/genetics | 2 | 1.0 |
Mice, Inbred BALB C | 8 | 0.0 |
Insulin/blood | 4 | 0.0 |
*Obesity | 2 | 3.0 |
Risk Factors | 6 | 0.0 |
Age Factors | 14 | 0.0 |
Cross-Sectional Studies | 2 | 0.0 |
Sex Characteristics | 3 | 0.0 |
Alzheimer Disease/*genetics | 2 | 0.0 |
Apolipoproteins E/genetics | 3 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Cell Death/*physiology | 2 | 5.0 |
Carbazoles/pharmacology | 10 | 21.0 |
Cell Differentiation | 10 | 0.0 |
Proto-Oncogene Proteins c-fos/biosynthesis/genetics | 2 | 16.0 |
Receptor, trkA/genetics/*metabolism | 3 | 42.0 |
Receptor, trkB/genetics/*metabolism | 5 | 83.0 |
Apoptosis/drug effects/physiology | 5 | 5.0 |
Brain/*metabolism/pathology/physiopathology | 2 | 10.0 |
Caspases/metabolism | 5 | 0.0 |
Cytokines/*metabolism | 2 | 0.0 |
Parkinson Disease/*metabolism/pathology/physiopathology | 2 | 40.0 |
Dogs | 2 | 0.0 |
Neurons/pathology | 2 | 1.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Neuronal Plasticity | 6 | 22.0 |
Neurons/drug effects/metabolism | 7 | 16.0 |
Photic Stimulation | 3 | 4.0 |
Alternative Splicing | 5 | 0.0 |
Brain-Derived Neurotrophic Factor/*biosynthesis | 6 | 100.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Neuroblastoma/*metabolism | 3 | 5.0 |
RNA, Messenger/*metabolism | 8 | 1.0 |
Up-Regulation/physiology | 3 | 2.0 |
Brain-Derived Neurotrophic Factor/metabolism/pharmacology | 2 | 100.0 |
*DNA-Binding Proteins | 4 | 0.0 |
Nerve Growth Factors/*metabolism/pharmacology | 2 | 18.0 |
Protein Transport/drug effects | 2 | 3.0 |
COS Cells | 5 | 0.0 |
Cercopithecus aethiops | 4 | 0.0 |
Glycosylation | 3 | 0.0 |
Mutagenesis, Site-Directed | 7 | 0.0 |
Neuroglia/metabolism | 2 | 2.0 |
Recombinant Proteins/biosynthesis/metabolism | 2 | 1.0 |
Alzheimer Disease/*metabolism/pathology | 5 | 5.0 |
*Brain Chemistry | 3 | 1.0 |
Postmortem Changes | 4 | 5.0 |
Antidepressive Agents/adverse effects/*therapeutic use | 2 | 100.0 |
Neuronal Plasticity/*drug effects/physiology | 2 | 50.0 |
Fibroblast Growth Factor 2/*pharmacology | 4 | 3.0 |
Cell Death/physiology | 5 | 6.0 |
Neurons/cytology/*physiology | 3 | 9.0 |
Dyes | 2 | 1.0 |
Fluorescent Dyes | 6 | 1.0 |
Rats, Inbred WKY | 2 | 2.0 |
Receptors, Nerve Growth Factor/genetics/*metabolism | 6 | 37.0 |
Staining and Labeling | 3 | 0.0 |
Cerebral Cortex/*metabolism | 3 | 5.0 |
Gene Expression/*physiology | 4 | 5.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Heterozygote | 7 | 0.0 |
Antipsychotic Agents/*therapeutic use | 2 | 6.0 |
Biological Markers | 7 | 0.0 |
Isoenzymes/metabolism | 3 | 0.0 |
Phospholipase C/metabolism | 4 | 1.0 |
Receptor, trkB/drug effects/*physiology | 3 | 100.0 |
Brain-Derived Neurotrophic Factor/genetics/metabolism | 2 | 100.0 |
Microtubule-Associated Proteins/metabolism | 3 | 2.0 |
Nerve Growth Factor/genetics/metabolism | 3 | 50.0 |
Nerve Growth Factors/biosynthesis/*pharmacology | 3 | 100.0 |
Neurons/cytology/*drug effects/metabolism | 3 | 18.0 |
Neuroprotective Agents/metabolism/*pharmacology | 2 | 100.0 |
Neurotrophin 3/genetics/metabolism | 3 | 100.0 |
Nerve Growth Factors/biosynthesis/*genetics | 3 | 100.0 |
Alzheimer Disease/*metabolism | 7 | 3.0 |
Parkinson Disease/*metabolism | 2 | 7.0 |
Logistic Models | 2 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Maze Learning/drug effects/physiology | 2 | 28.0 |
Brain-Derived Neurotrophic Factor/*genetics/*metabolism | 3 | 100.0 |
*Gene Transfer Techniques | 4 | 1.0 |
Genetic Vectors/genetics | 4 | 1.0 |
Simplexvirus/*genetics | 2 | 7.0 |
Apoptosis/*physiology | 4 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
DNA Fragmentation/drug effects | 2 | 2.0 |
Flavonoids/pharmacology | 4 | 1.0 |
Receptor, trkA/biosynthesis | 2 | 66.0 |
Receptor, trkB/biosynthesis | 2 | 100.0 |
Corpus Striatum/metabolism | 3 | 12.0 |
Hippocampus/drug effects/*metabolism | 2 | 28.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Bucladesine/pharmacology | 4 | 2.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 3 | 1.0 |
Glioma | 3 | 4.0 |
Growth Substances/*pharmacology | 3 | 0.0 |
Hela Cells | 4 | 0.0 |
Neuroblastoma | 9 | 4.0 |
Neurons/cytology/drug effects/*physiology | 4 | 20.0 |
Tetradecanoylphorbol Acetate/pharmacology | 6 | 0.0 |
*Trans-Activators | 2 | 0.0 |
Transcription, Genetic/*drug effects | 4 | 1.0 |
Antigens, Differentiation/biosynthesis | 2 | 3.0 |
*Cell Differentiation/drug effects | 2 | 6.0 |
Coculture Techniques | 5 | 0.0 |
Corpus Striatum/cytology | 2 | 66.0 |
Epidermal Growth Factor/pharmacology | 4 | 0.0 |
Growth Inhibitors/pharmacology | 3 | 2.0 |
*Interleukin-6 | 2 | 0.0 |
Lymphokines/pharmacology | 2 | 1.0 |
Mesencephalon/cytology | 4 | 50.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 40 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human, Pair 11/*genetics | 3 | 1.0 |
Hybrid Cells | 5 | 0.0 |
Neurons/*cytology | 4 | 6.0 |
RNA, Messenger | 3 | 0.0 |
Autopsy | 2 | 1.0 |
Cause of Death | 2 | 1.0 |
Gene Expression Regulation/drug effects | 9 | 1.0 |
Receptor, trkB/*genetics | 4 | 80.0 |
Hippocampus/physiology | 3 | 20.0 |
Synapses/*physiology | 6 | 17.0 |
Up-Regulation/drug effects | 5 | 1.0 |
Catalysis | 2 | 0.0 |
Oxidation-Reduction | 3 | 0.0 |
Solubility | 4 | 0.0 |
Solvents | 2 | 3.0 |
Neuropsychological Tests | 3 | 1.0 |
Questionnaires | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/*physiology | 14 | 87.0 |
*Transcription, Genetic | 6 | 0.0 |
T-Lymphocytes/immunology | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/*cerebrospinal fluid | 2 | 100.0 |
Neuroprotective Agents/therapeutic use | 2 | 20.0 |
Cell Differentiation/*drug effects | 3 | 1.0 |
DNA, Neoplasm/biosynthesis | 3 | 2.0 |
Down-Regulation | 3 | 0.0 |
Flow Cytometry | 6 | 0.0 |
Receptors, Nerve Growth Factor/biosynthesis/genetics | 3 | 60.0 |
Brain Chemistry/*genetics | 2 | 4.0 |
Brain/anatomy & histology/physiology | 2 | 100.0 |
Brain Mapping | 2 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Magnetic Resonance Imaging | 6 | 0.0 |
Biological Transport | 3 | 0.0 |
Brain/pathology | 3 | 0.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Drug Therapy, Combination | 2 | 0.0 |
RNA, Messenger/genetics | 12 | 0.0 |
Spinal Cord/*metabolism | 2 | 6.0 |
Tyrosine/metabolism | 8 | 0.0 |
Oligodendroglia/physiology | 2 | 50.0 |
Receptors, Nerve Growth Factor/*physiology | 4 | 28.0 |
Sequence Alignment | 8 | 0.0 |
*Signal Transduction/drug effects | 2 | 2.0 |
3,4-Dihydroxyphenylacetic Acid/metabolism | 3 | 11.0 |
Brain-Derived Neurotrophic Factor/genetics/*physiology | 5 | 100.0 |
Denervation | 6 | 17.0 |
Hydroxyindoleacetic Acid/metabolism | 2 | 14.0 |
Neurotoxins/toxicity | 2 | 28.0 |
Protein Precursors/genetics | 3 | 3.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
*Transfection | 2 | 0.0 |
Brain-Derived Neurotrophic Factor/analysis/*biosynthesis | 4 | 100.0 |
DNA/analysis | 2 | 0.0 |
Gerbillinae | 2 | 5.0 |
Brain/cytology | 2 | 7.0 |
Cattle | 3 | 0.0 |
Forskolin/pharmacology | 5 | 1.0 |
Muscle, Smooth, Vascular/cytology/metabolism | 2 | 6.0 |
RNA, Messenger/analysis/genetics | 4 | 0.0 |
Transforming Growth Factor beta/pharmacology | 3 | 0.0 |
Cisplatin/pharmacology | 4 | 2.0 |
Doxorubicin/pharmacology | 3 | 1.0 |
Cerebrovascular Circulation/physiology | 2 | 9.0 |
Infusion Pumps | 2 | 7.0 |
Dopamine/*metabolism | 10 | 9.0 |
Stimulation, Chemical | 3 | 0.0 |
Substantia Nigra/cytology/*metabolism | 2 | 22.0 |
Body Weight/drug effects | 4 | 2.0 |
Leptin/blood | 3 | 5.0 |
Organ Culture Techniques | 8 | 2.0 |
Autoradiography | 9 | 1.0 |
*Axonal Transport | 3 | 50.0 |
Macaca fascicularis | 2 | 0.0 |
Rats, Inbred BN | 2 | 4.0 |
Rabbits | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
Behavior, Animal/drug effects | 2 | 4.0 |
Ciliary Neurotrophic Factor/pharmacology | 2 | 20.0 |
Drug Interactions | 8 | 0.0 |
Retina/pathology | 2 | 5.0 |
Cations | 2 | 2.0 |
Neurons/physiology | 7 | 6.0 |
Herpesvirus 4, Human | 2 | 1.0 |
*Membrane Transport Proteins | 2 | 0.0 |
Neuroblastoma/metabolism | 3 | 5.0 |
Brain/drug effects | 2 | 14.0 |
Neurons/metabolism/pathology | 2 | 2.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Fetus/metabolism | 3 | 1.0 |
Gestational Age | 4 | 0.0 |
Histocytochemistry | 2 | 0.0 |
Nervous System Physiology | 3 | 14.0 |
Neurotrophin 3/*genetics | 2 | 33.0 |
Thiolester Hydrolases/metabolism | 2 | 11.0 |
Mice, Obese | 2 | 4.0 |
Nerve Growth Factors/analysis/*metabolism | 3 | 75.0 |
DNA Fragmentation | 4 | 1.0 |
Nerve Degeneration/metabolism | 2 | 25.0 |
Nerve Regeneration/physiology | 4 | 17.0 |
Brain-Derived Neurotrophic Factor/*chemistry | 2 | 100.0 |
Crystallization | 2 | 0.0 |
Nerve Growth Factors/*chemistry | 5 | 45.0 |
Infusions, Parenteral | 4 | 2.0 |
Receptor, trkA/genetics/metabolism | 2 | 50.0 |
Receptor, trkB/genetics/metabolism | 7 | 100.0 |
Serotonin/*physiology | 2 | 7.0 |
Astrocytes/cytology/metabolism | 2 | 11.0 |
Enzyme Activation | 10 | 0.0 |
Neurons/cytology/*metabolism | 4 | 4.0 |
Behavior, Animal | 5 | 6.0 |
Brain-Derived Neurotrophic Factor/*deficiency/genetics | 3 | 100.0 |
Proto-Oncogene Proteins c-fos/biosynthesis | 3 | 9.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Molecular Weight | 6 | 0.0 |
Peptide Mapping | 3 | 0.0 |
Serine Endopeptidases/metabolism | 2 | 1.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Chick Embryo | 15 | 2.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 4 | 2.0 |
Nerve Growth Factors/metabolism/pharmacology | 2 | 33.0 |
Kindling (Neurology) | 2 | 28.0 |
Chromatography, Gel | 5 | 0.0 |
Guanidine | 3 | 11.0 |
Macromolecular Substances | 8 | 0.0 |
Nerve Growth Factors/*chemistry/metabolism | 3 | 75.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/*therapeutic use | 3 | 100.0 |
Retrospective Studies | 2 | 0.0 |
Gene Expression/genetics | 2 | 0.0 |
Haplotypes/genetics | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Variation (Genetics)/genetics | 2 | 1.0 |
Cell Line, Tumor | 11 | 0.0 |
Adrenergic Agents | 2 | 50.0 |
Amphetamine/pharmacology | 3 | 33.0 |
Brain-Derived Neurotrophic Factor/*genetics/metabolism | 8 | 100.0 |
Central Nervous System Stimulants/pharmacology | 2 | 16.0 |
Motor Activity/*genetics | 2 | 50.0 |
Oxidopamine | 2 | 4.0 |
Parkinson Disease/therapy | 5 | 45.0 |
Substantia Nigra/drug effects/*metabolism | 2 | 50.0 |
Animals, Newborn/growth & development/*metabolism | 2 | 50.0 |
Embryonic and Fetal Development/physiology | 3 | 3.0 |
Recombinant Proteins/pharmacology | 29 | 1.0 |
Tetrodotoxin/pharmacology | 2 | 5.0 |
Xenopus laevis | 3 | 0.0 |
Immunoblotting | 6 | 0.0 |
Acetylcholine/*physiology | 5 | 27.0 |
Cats | 5 | 1.0 |
Cholinergic Fibers/*physiology | 3 | 37.0 |
Insulin-Like Growth Factor I/pharmacology | 3 | 1.0 |
Nerve Growth Factors/*pharmacology/physiology | 3 | 75.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Membrane Proteins/metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Serine/metabolism | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
*Disease Models, Animal | 5 | 1.0 |
Rats, Inbred Lew | 3 | 1.0 |
Microscopy, Confocal | 3 | 0.0 |
Potassium/pharmacology | 2 | 3.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 2 | 0.0 |
Chromones/pharmacology | 3 | 1.0 |
Mitogen-Activated Protein Kinase 1 | 3 | 2.0 |
*Mitogen-Activated Protein Kinases | 5 | 1.0 |
Morpholines/pharmacology | 3 | 1.0 |
Neurites/drug effects/*physiology | 2 | 18.0 |
Neuroprotective Agents/pharmacology | 9 | 25.0 |
Neurotrophin 3 | 76 | 89.0 |
Receptor, Ciliary Neurotrophic Factor | 51 | 57.0 |
Receptor, trkA | 25 | 43.0 |
Receptors, Nerve Growth Factor/genetics | 5 | 31.0 |
Excitatory Postsynaptic Potentials/drug effects/physiology | 2 | 33.0 |
Glutamic Acid/physiology | 2 | 18.0 |
Hippocampus/cytology/drug effects | 3 | 37.0 |
Membrane Potentials/drug effects/physiology | 3 | 3.0 |
Patch-Clamp Techniques | 7 | 1.0 |
Synapses/*drug effects/*physiology | 2 | 100.0 |
Synaptic Transmission/drug effects/*physiology | 3 | 42.0 |
gamma-Aminobutyric Acid/physiology | 3 | 25.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Hippocampus/*physiology | 4 | 13.0 |
Long-Term Potentiation/*physiology | 2 | 28.0 |
Transcription Factors/genetics | 2 | 0.0 |
Long-Term Potentiation/physiology | 2 | 28.0 |
Membrane Proteins/physiology | 2 | 2.0 |
Nerve Tissue Proteins/physiology | 3 | 7.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 5 | 1.0 |
Gene Expression/physiology | 3 | 0.0 |
Phosphoproteins/metabolism | 3 | 0.0 |
Nitric-Oxide Synthase/*metabolism | 2 | 2.0 |
Cell Aggregation | 2 | 1.0 |
Cell Culture Techniques/*methods | 4 | 4.0 |
Culture Media, Serum-Free | 3 | 0.0 |
Fetus/*cytology | 3 | 16.0 |
Neurons/cytology | 2 | 4.0 |
Neuropeptide Y/biosynthesis | 2 | 40.0 |
Receptors, Nerve Growth Factor/genetics/physiology | 3 | 100.0 |
Mice, Neurologic Mutants | 4 | 3.0 |
Swine | 3 | 0.0 |
Drug Synergism | 6 | 0.0 |
Neuroblastoma/*pathology | 4 | 7.0 |
*Potassium Channels, Voltage-Gated | 3 | 1.0 |
Tretinoin/*pharmacology | 5 | 1.0 |
Frontal Lobe/metabolism | 2 | 6.0 |
Antibodies | 7 | 1.0 |
Antisense Elements (Genetics) | 2 | 3.0 |
Gene Expression/immunology | 2 | 2.0 |
Ganglia, Spinal/cytology | 4 | 16.0 |
Mice, Inbred C3H | 3 | 0.0 |
Organ Specificity | 7 | 0.0 |
Trigeminal Ganglion/cytology | 2 | 66.0 |
Neurons, Afferent/physiology | 2 | 6.0 |
Extracellular Space/metabolism | 2 | 3.0 |
Receptor Protein-Tyrosine Kinases/physiology | 3 | 6.0 |
Receptors, Nerve Growth Factor/physiology | 7 | 43.0 |
Recombinant Fusion Proteins/pharmacology | 3 | 3.0 |
Receptor, Nerve Growth Factor | 15 | 51.0 |
Synaptic Transmission/*drug effects | 2 | 12.0 |
Adenoviridae/*genetics | 4 | 1.0 |
Genetic Vectors | 5 | 0.0 |
Exons/*genetics | 2 | 0.0 |
Clone Cells | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis/genetics | 4 | 11.0 |
Receptors, Nerve Growth Factor/*biosynthesis/genetics | 5 | 100.0 |
Axons/physiology | 5 | 10.0 |
Behavior, Animal/physiology | 2 | 7.0 |
Graft Survival | 3 | 0.0 |
*Nerve Regeneration | 3 | 21.0 |
*Fetal Tissue Transplantation | 2 | 8.0 |
*Gestational Age | 2 | 3.0 |
Nerve Growth Factors | 3 | 75.0 |
Dopamine/pharmacology | 2 | 5.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 2 | 1.0 |
Neurons/*enzymology | 2 | 2.0 |
Cell Count/drug effects | 2 | 2.0 |
Lac Operon | 3 | 2.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*analysis | 2 | 4.0 |
Receptors, Nerve Growth Factor/*analysis | 4 | 26.0 |
Cell Survival/physiology | 10 | 5.0 |
Cadaver | 2 | 0.0 |
Neurons/metabolism/ultrastructure | 2 | 11.0 |
Cell Size | 5 | 1.0 |
JNK Mitogen-Activated Protein Kinases | 3 | 0.0 |
tau Proteins/*metabolism | 2 | 4.0 |
Brain/*drug effects/metabolism/physiopathology | 2 | 50.0 |
Neuronal Plasticity/drug effects/physiology | 2 | 33.0 |
Amyotrophic Lateral Sclerosis/*metabolism/pathology | 3 | 25.0 |
Proteins/metabolism | 4 | 0.0 |
Stress/metabolism | 2 | 22.0 |
*Apoptosis | 2 | 0.0 |
Brain-Derived Neurotrophic Factor/physiology | 8 | 88.0 |
Cerebellum/*cytology | 4 | 44.0 |
Cell Culture Techniques/methods | 3 | 1.0 |
Ciliary Neurotrophic Factor | 19 | 15.0 |
Nerve Growth Factors/administration & dosage/*metabolism/pharmacology | 2 | 100.0 |
Neurons/pathology/physiology | 2 | 25.0 |
Neuronal Plasticity/drug effects | 4 | 36.0 |
Models, Animal | 3 | 1.0 |
Nerve Regeneration/*drug effects | 4 | 44.0 |
Neostriatum/metabolism/pathology | 2 | 100.0 |
Optic Nerve/physiology | 2 | 50.0 |
Retinal Ganglion Cells/drug effects/*physiology | 2 | 66.0 |
Nerve Growth Factors/*biosynthesis/genetics | 2 | 33.0 |
Receptor Protein-Tyrosine Kinases/biosynthesis/genetics | 2 | 12.0 |
Morphogenesis/physiology | 2 | 6.0 |
Nerve Tissue Proteins/*physiology | 3 | 4.0 |
Astrocytes/physiology | 2 | 13.0 |
Energy Metabolism/*physiology | 2 | 2.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Neuroprotective Agents/*analysis | 2 | 66.0 |
Injections, Intravenous | 3 | 0.0 |
Recombinant Proteins/pharmacokinetics | 3 | 16.0 |
Regression Analysis | 3 | 0.0 |
Nerve Regeneration/*physiology | 5 | 19.0 |
HIV Envelope Protein gp120/*pharmacology | 2 | 4.0 |
Neurons/drug effects/*metabolism | 7 | 19.0 |
Drug Stability | 2 | 0.0 |
Recombinant Proteins/chemistry | 4 | 1.0 |
*Blood-Brain Barrier | 2 | 8.0 |
Drug Design | 3 | 0.0 |
Brain-Derived Neurotrophic Factor/blood | 2 | 100.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Schizophrenia/diagnosis/*genetics | 2 | 13.0 |
Adenoviridae/genetics | 2 | 0.0 |
Axonal Transport | 3 | 18.0 |
Gene Therapy/*methods | 2 | 0.0 |
Gene Transfer Techniques | 6 | 1.0 |
Nerve Growth Factors/metabolism/*pharmacology | 5 | 38.0 |
Receptors, Nerve Growth Factor/drug effects/*physiology | 2 | 100.0 |
Fetus/cytology | 2 | 3.0 |
Computer Simulation | 4 | 1.0 |
Dimerization | 3 | 0.0 |
Apoptosis/*drug effects | 3 | 0.0 |
Etoposide/pharmacology | 3 | 2.0 |
Neurons/*cytology/drug effects/metabolism | 3 | 42.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
Cerebral Cortex/cytology/*physiology | 2 | 50.0 |
Enzyme-Linked Immunosorbent Assay/methods | 3 | 1.0 |
Fibroblast Growth Factors/pharmacology | 3 | 4.0 |
Neuroglia/cytology/drug effects | 2 | 66.0 |
Choline O-Acetyltransferase/*metabolism | 2 | 1.0 |
Neocortex/metabolism | 2 | 66.0 |
Axonal Transport/*physiology | 2 | 25.0 |
Neurons, Afferent/*metabolism | 2 | 11.0 |
Neurotransmitters/metabolism | 2 | 5.0 |
Nerve Growth Factors/administration & dosage/*pharmacology | 2 | 28.0 |
Neurons, Afferent/*drug effects | 2 | 66.0 |
Brain Chemistry/*physiology | 4 | 6.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Synapses/drug effects/*physiology | 3 | 60.0 |
Rats, Inbred Strains | 8 | 1.0 |
Neurons/drug effects/ultrastructure | 2 | 100.0 |
Antidepressive Agents/*pharmacology | 3 | 11.0 |
Brain-Derived Neurotrophic Factor/drug effects | 2 | 100.0 |
Second Messenger Systems/physiology | 2 | 5.0 |
Serotonin/physiology | 2 | 6.0 |
Axons/*physiology | 5 | 10.0 |
Schwann Cells/*metabolism | 2 | 12.0 |
Embryonic and Fetal Development/drug effects | 2 | 9.0 |
Spinal Cord/*pathology | 2 | 10.0 |
Aging/physiology | 2 | 1.0 |
Axonal Transport/physiology | 2 | 22.0 |
Biological Transport/physiology | 3 | 1.0 |
Electric Stimulation | 3 | 1.0 |
Genetic Engineering | 5 | 5.0 |
Nerve Growth Factors/genetics/*secretion | 2 | 40.0 |
Retroviridae | 2 | 2.0 |
Receptors, Nerve Growth Factor/drug effects/physiology | 2 | 100.0 |
Conserved Sequence | 3 | 0.0 |
Nerve Growth Factors/analysis/*biosynthesis | 2 | 50.0 |
Variation (Genetics)/*genetics | 4 | 1.0 |
Electrophoretic Mobility Shift Assay/methods | 2 | 9.0 |
*Receptor, trkA | 2 | 16.0 |
*Drug Delivery Systems | 2 | 6.0 |
Nerve Tissue Proteins/analysis | 2 | 2.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 2 | 3.0 |
DNA, Complementary/genetics | 5 | 0.0 |
Nerve Regeneration | 3 | 18.0 |
Biotin | 2 | 3.0 |
Proto-Oncogene Proteins/analysis | 4 | 2.0 |
Receptor Protein-Tyrosine Kinases/analysis | 5 | 10.0 |
Cell Division/drug effects/physiology | 4 | 1.0 |
Tyrosine 3-Monooxygenase/metabolism | 7 | 4.0 |
Ubiquitin Thiolesterase/metabolism | 2 | 33.0 |
Neuroblastoma/*metabolism/*pathology | 2 | 33.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Receptors, Nerve Growth Factor/*genetics | 6 | 19.0 |
Drug Combinations | 2 | 0.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Necrosis | 2 | 0.0 |
Nerve Degeneration/physiopathology | 2 | 40.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Methionine/genetics | 5 | 10.0 |
Valine/genetics | 4 | 5.0 |
Nerve Tissue Proteins/*biosynthesis | 3 | 9.0 |
Infant, Premature | 2 | 1.0 |
Nerve Growth Factors/*analysis | 3 | 20.0 |
Atrophy | 3 | 2.0 |
Axons/drug effects/physiology | 2 | 22.0 |
Motor Neurons/*pathology | 2 | 10.0 |
Nerve Growth Factors/genetics | 6 | 19.0 |
Neurons/*drug effects/metabolism | 4 | 20.0 |
Neuropeptide Y/*biosynthesis | 3 | 27.0 |
Polymorphism, Single Nucleotide/genetics | 3 | 1.0 |
Chelating Agents/pharmacology | 2 | 2.0 |
Nerve Growth Factor/biosynthesis | 2 | 100.0 |
Brain-Derived Neurotrophic Factor/pharmacology/*physiology | 3 | 100.0 |
Memory/physiology | 2 | 6.0 |
Morphogenesis/drug effects | 3 | 13.0 |
Neurites/drug effects/ultrastructure | 2 | 40.0 |
Neurons/*drug effects | 9 | 23.0 |
Chromatography, Affinity | 3 | 0.0 |
Cross-Linking Reagents | 6 | 1.0 |
DNA/analysis/genetics | 2 | 1.0 |
Genetic Predisposition to Disease/genetics | 5 | 1.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 6 | 2.0 |
Blood Platelets/*metabolism | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
*Cell Survival | 2 | 5.0 |
Retinal Ganglion Cells/cytology/*physiology | 2 | 50.0 |
Nerve Tissue Proteins/*genetics/metabolism/pharmacology | 2 | 66.0 |
*Transduction, Genetic | 2 | 2.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 2 | 1.0 |
Nerve Tissue Proteins/*genetics/pharmacology | 3 | 75.0 |
Antibody Specificity | 2 | 0.0 |
Dopamine/*physiology | 2 | 2.0 |
Fetal Tissue Transplantation/*physiology | 2 | 20.0 |
Rotation | 2 | 4.0 |
Tyrosine 3-Monooxygenase/analysis | 2 | 2.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Hippocampus/drug effects/enzymology | 2 | 50.0 |
Alzheimer Disease/epidemiology/*genetics | 2 | 3.0 |
DNA, Complementary | 2 | 0.0 |
Nerve Tissue Proteins/drug effects/physiology | 2 | 100.0 |
Choline O-Acetyltransferase/metabolism | 10 | 6.0 |
Enzyme Activation/physiology | 2 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Nerve Growth Factors/*biosynthesis | 4 | 28.0 |
*Neuroblastoma | 2 | 10.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Chickens | 7 | 0.0 |
Escherichia coli | 2 | 0.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
RNA, Messenger/*analysis | 2 | 0.0 |
Cells, Cultured/cytology/drug effects | 2 | 18.0 |
Dopamine/physiology | 2 | 3.0 |
Proto-Oncogene Proteins/biosynthesis | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/biosynthesis | 2 | 6.0 |
Receptors, Nerve Growth Factor/biosynthesis | 3 | 50.0 |
Brain/physiology | 3 | 4.0 |
Brain-Derived Neurotrophic Factor/metabolism/*physiology | 2 | 100.0 |
*Gene Therapy | 3 | 0.0 |
Recombinant Proteins/biosynthesis | 4 | 0.0 |
Abortion, Induced | 2 | 6.0 |
Pedigree | 3 | 0.0 |
Kidney/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/biosynthesis | 2 | 8.0 |
Brain-Derived Neurotrophic Factor | 85 | 96.0 |
Nerve Tissue Proteins/genetics/*pharmacology | 2 | 40.0 |
ras Proteins/*metabolism | 2 | 1.0 |
Nerve Tissue Proteins/biosynthesis | 2 | 8.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Receptors, Nerve Growth Factor/*biosynthesis | 2 | 28.0 |
Motor Neurons/*physiology | 2 | 3.0 |
Substantia Nigra/drug effects/metabolism | 2 | 40.0 |
Immunoglobulin G/immunology | 2 | 0.0 |
Nerve Degeneration/*drug effects | 4 | 50.0 |
Rats, Inbred F344 | 9 | 2.0 |
Neurites/*drug effects | 2 | 33.0 |
Acetylcholine/physiology | 2 | 20.0 |
Molecular Biology | 2 | 0.0 |
Nerve Tissue Proteins/genetics | 5 | 1.0 |
Motor Neurons/drug effects/*physiology | 2 | 66.0 |
Mitosis | 2 | 0.0 |
Neurons, Afferent/drug effects/*physiology | 2 | 33.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Nerve Regeneration/genetics/physiology | 2 | 100.0 |
Nerve Tissue Proteins/genetics/*secretion | 2 | 66.0 |
Nerve Tissue Proteins/metabolism | 9 | 4.0 |
Neuroprotective Agents/*therapeutic use | 2 | 8.0 |
Culture Media | 2 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Molecular Probes/genetics | 2 | 2.0 |
Neurites/physiology | 2 | 10.0 |
*Antigens, CD | 2 | 0.0 |
Molecular Structure | 3 | 0.0 |
Nerve Growth Factors/physiology | 3 | 15.0 |
Motor Neurons/*drug effects | 2 | 25.0 |
Receptors, Nerve Growth Factor/drug effects/metabolism | 2 | 66.0 |
Recombinant Proteins | 7 | 0.0 |
Intermediate Filament Proteins/metabolism | 2 | 4.0 |
Receptors, Growth Factor/physiology | 2 | 4.0 |
Nerve Growth Factors/*therapeutic use | 2 | 33.0 |
Peptides/metabolism | 2 | 0.0 |
Glutamic Acid/pharmacology | 2 | 13.0 |
Brain/anatomy & histology/*metabolism | 2 | 15.0 |
Nerve Growth Factors/biosynthesis/genetics | 2 | 50.0 |
Sequence Tagged Sites | 2 | 0.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Arteriosclerosis/metabolism | 2 | 3.0 |
Cell Movement | 2 | 0.0 |
Antibodies/immunology | 2 | 0.0 |
Antidepressive Agents/pharmacology | 2 | 33.0 |
Dopamine/analysis/*metabolism | 2 | 33.0 |
Thymidine/metabolism | 2 | 0.0 |
Nerve Tissue Proteins/*chemistry | 4 | 11.0 |
Nerve Tissue Proteins/*therapeutic use | 2 | 33.0 |
Body Weight | 2 | 0.0 |
Hippocampus/metabolism/pathology | 2 | 6.0 |
Cell Differentiation/drug effects/genetics | 3 | 5.0 |
Stem Cells/cytology/drug effects/*metabolism | 2 | 15.0 |
Molecular Conformation | 2 | 0.0 |
RNA, Messenger/*genetics | 3 | 0.0 |
WAGR Syndrome/*genetics | 2 | 40.0 |
Biological Assay | 2 | 0.0 |
*Protein Conformation | 2 | 0.0 |
Protein Denaturation | 3 | 1.0 |
*Protein Folding | 2 | 1.0 |
*Chromosomes, Human, Pair 11 | 3 | 0.0 |
DNA/biosynthesis | 2 | 0.0 |
Iodine Radioisotopes | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Cerebral Ventricles/drug effects/*physiology | 2 | 20.0 |
Nerve Tissue Proteins/administration & dosage/*pharmacology | 2 | 28.0 |
Proto-Oncogenes | 2 | 1.0 |
*Nerve Growth Factors/chemistry/genetics/metabolism | 2 | 100.0 |
*Brain-Derived Neurotrophic Factor | 2 | 66.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Growth Substances/pharmacology | 2 | 1.0 |
Regeneration/physiology | 2 | 11.0 |
Amyloid beta-Protein Precursor/*metabolism | 2 | 2.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 2 | 1.0 |
Brain Ischemia/metabolism | 3 | 37.0 |
Genes, myc | 2 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 2 | 0.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Prosencephalon/cytology/*physiology | 2 | 40.0 |
Brain Diseases/*metabolism | 2 | 50.0 |
Exocytosis | 3 | 4.0 |
RNA/metabolism | 2 | 0.0 |
Neurodegenerative Diseases/*drug therapy | 2 | 50.0 |
Gene Expression Regulation/physiology | 5 | 1.0 |
Calcium-Binding Proteins/metabolism | 2 | 2.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Nerve Tissue Proteins/genetics/physiology | 2 | 11.0 |
*Schizophrenic Psychology | 2 | 3.0 |
Transplantation, Heterologous | 2 | 0.0 |
Nerve Growth Factors/metabolism/*therapeutic use | 2 | 66.0 |
Receptor, trkC/genetics/metabolism | 2 | 40.0 |
Synapses/metabolism | 4 | 21.0 |
Brain Chemistry/drug effects | 2 | 12.0 |
Receptors, Nerve Growth Factor | 4 | 8.0 |
Evolution | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 3 | 0.0 |
DNA/genetics | 3 | 0.0 |
Nervous System Diseases/blood/immunology | 2 | 66.0 |
Choline/metabolism | 2 | 5.0 |
Eating/*drug effects | 2 | 10.0 |
Hippocampus/*drug effects | 3 | 33.0 |
Weight Gain/*drug effects | 2 | 33.0 |
*Age of Onset | 2 | 8.0 |
Mood Disorders/*genetics | 2 | 12.0 |
*Suicide | 2 | 11.0 |
Placenta/physiology | 2 | 5.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Quantitative Trait Loci/genetics | 2 | 20.0 |
Oncogene Proteins/*genetics | 2 | 1.0 |
*Oncogenes | 2 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 6 | 0.0 |
Chromosomes, Human, Pair 12 | 2 | 1.0 |
Phylogeny | 2 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Cognition | 2 | 3.0 |
Nerve Tissue Proteins/genetics/metabolism | 2 | 2.0 |
Kidney | 2 | 0.0 |
Neurons/*cytology/drug effects/physiology | 2 | 25.0 |
Dendrites/*metabolism | 2 | 20.0 |
Synapses/*metabolism | 3 | 16.0 |
Bipolar Disorder/*genetics | 4 | 3.0 |
Membrane Potentials/physiology | 2 | 2.0 |
Mass Fragmentography | 2 | 0.0 |
Physical Conditioning, Animal/*physiology | 2 | 50.0 |
Brain-Derived Neurotrophic Factor/*blood/drug effects | 2 | 100.0 |
Nerve Growth Factors/genetics/*physiology | 2 | 40.0 |
*Avian Proteins | 2 | 2.0 |
Immunoglobulin G/pharmacology | 2 | 3.0 |
Motor Activity/drug effects/physiology | 2 | 22.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Neurons/cytology/metabolism | 2 | 2.0 |
Biological Markers/blood | 2 | 0.0 |
Maryland | 2 | 20.0 |
Cohort Studies | 2 | 0.0 |
Receptors, N-Methyl-D-Aspartate/*metabolism | 2 | 18.0 |
Antidepressive Agents/pharmacology/*therapeutic use | 2 | 40.0 |
Brain-Derived Neurotrophic Factor/*metabolism/*physiology | 2 | 100.0 |
Neuroprotective Agents/metabolism | 2 | 13.0 |
Huntington Disease/*physiopathology | 2 | 33.0 |
Eosinophils/*metabolism | 2 | 6.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Brain Chemistry/*drug effects | 2 | 12.0 |
Diabetes Mellitus, Experimental/complications | 2 | 66.0 |
Energy Intake/physiology | 2 | 7.0 |
*Memory | 2 | 12.0 |
Neurons/drug effects/physiology | 2 | 9.0 |
Interferon Type II/metabolism | 2 | 0.0 |
Multiple Sclerosis, Relapsing-Remitting/drug therapy/*immunology | 2 | 66.0 |
Bone Marrow Cells/*drug effects/metabolism | 2 | 40.0 |
Stromal Cells/*drug effects/metabolism | 2 | 40.0 |
Enzyme Activators/pharmacology | 2 | 10.0 |
Down-Regulation/drug effects/physiology | 2 | 5.0 |
Hippocampus/cytology/*physiology | 2 | 18.0 |
Protein Transport | 2 | 0.0 |
Leukocytes, Mononuclear/drug effects/*metabolism | 2 | 5.0 |
Cytokines/metabolism | 2 | 0.0 |
Stress, Psychological/*physiopathology | 2 | 16.0 |
